Search results
Author(s):
Myriam Edjlali-Goujon
,
Daniel Alison
Added:
3 years ago
Digital ischaemia is an uncommon pathology, with an incidence of two cases per 100,000 people per year.1 Diagnosis is mainly based on clinical symptoms: the patient presents a painful digital extremity with signs of ischaemia (blue finger) or even necrosis. Clinical context and medical history are also important to determine the aetiology of digital ischaemia.
The role of imaging modalities is…
View more
Andreas Hammer
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Mary N Sheppard
Added:
3 years ago
Takotsubo syndrome is an acute reversible heart failure syndrome, which is increasingly recognised by coronary angiography for patients with acute ‘cardiac’ chest pain.1 It is a distinct disease entity from acute coronary syndrome, although the initial presentation has similar features to either ST elevation myocardial infarction (STEMI) or non-ST elevation myocardial infarction (NSTEMI). Early…
View more
Author(s):
Syed Khurram Mushtaq Gardezi
Added:
3 years ago
Today, in cardiology, acute coronary syndrome (ACS) is one of the most common presentations in hospitals. Usually, the history and presenting features of ACS are very typical. However, some patients have an atypical presentation, which can pose a problem for prompt diagnosis and management, leading to an overall increase in morbidity and mortality in such patients.
Case Presentation
A 61-year…
View more
Author(s):
Konstantinos Bratis
Added:
3 years ago
Takotsubo syndrome (TTS) is an acute, profound, but reversible heart failure syndrome, usually but not always triggered by physical or emotional stress. To date, the exact pathogenic mechanism of this syndrome remains unclear; however, several hypotheses involving vascular mechanisms (i.e. abnormal coronary epicardial or microvascular vasoreactivity),1-3 endocrine and gender-related mechanisms (i…
View more
Author(s):
Kerry Layne
,
Albert Ferro
Added:
3 years ago
Acute coronary syndrome (ACS) is a term used to encompass unstable angina (UA) and myocardial infarction (MI) with or without electrocardiographic (ECG) evidence of ST-segment elevation. Antiplatelet therapy has formed the backbone of ACS management for decades and the drug class continues to evolve as novel agents with increasingly efficacious antiplatelet actions are identified. The main risk…
View more
Author(s):
Daniel García Iglesias
,
José Rubín
,
Diego Pérez
,
et al
Added:
3 years ago
Brugada syndrome (BrS) is an inherited disease with an increased risk of sudden cardiac death (SCD). Despite the wide spectrum of clinical manifestations, young and apparently healthy individuals are the most frequently affected by this devastating event.1,2 During the last 20 years, the genetic basis of Brugada syndrome has been extensively investigated, leading to major changes in gene encoding…
View more
Author(s):
Velislav N Batchvarov
Added:
3 years ago
The two most important, both medically and socially, cardiac arrhythmic problems of our time are sudden cardiac death due to ventricular fibrillation (VF) (mainly in the setting of coronary artery disease) and atrial fibrillation (AF). For both of them, the identification of electrocardiogram ( ECG) markers that can reliably predict the occurrence of the arrhythmia is generally an unresolved…
View more
Author(s):
Afik D Snir
,
Hariharan Raju
Added:
3 years ago
Brugada syndrome was first described in 1993 in a case series of eight patients with recurrent polymorphic ventricular tachycardia (VT) and stereotypical electrographic characteristics in the context of a structurally normal heart.1 Since then, the syndrome has been extensively studied and recognised worldwide as a major cause of sudden cardiac death (SCD) in otherwise healthy patients.2 Recent…
View more
Author(s):
Yukiko Isekame
,
Sabiha Gati
,
Jose Antonio Aragon-Martin
,
et al
Added:
3 years ago
Marfan syndrome (MFS) is a disease in which connective tissue becomes weak secondary to fibrillin-1 mutations, resulting in aortic dilatation, aneurysm formation, aortic dissection, aortic regurgitation and mitral valve prolapse (MVP; see Table 1).
Epidemiology
MFS is an autosomal dominant condition: 75 % of all patients inherit the condition from one affected parent and 25 % are affected as…
View more